Johan Louw

Johan Louw

Auto-generated profile, based on publicly available information

Johan Louw

Biomedical Research and Innovation Platform (BRIP), South African Medical Research Council (SAMRC), Tygerberg 7505, South Africa

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2018 in Nutrients
Verified
Journal Article
Open access
PDF file
PDPhiwayinkosi V. Dludla
Phiwayinkosi V. Dludla
BNBongani Nkambule
Bongani Nkambule
BJBabalwa Unice Jack
Babalwa Unice Jack
ZMZibusiso Mkandla
Zibusiso Mkandla
TMTinashe Mutize
Tinashe Mutize
SMSithandiwe Mazibuko-Mbeje
Sithandiwe Mazibuko-Mbeje
Metabolic complications in an obese state can be aggravated by an abnormal inflammatory response and enhanced production of reactive oxygen species. Pro-inflammatory response is known to be associated with the formation of toxic reactive oxygen species and subsequent generation of oxidative stress. Indeed, adipocytes from obese individuals display an altered adipokine profile, with upregulated expression and secretion of pro-inflammatory cytokines such as tumor necrosis factor alpha (TNF-α) and interleukin (IL-6). Interestingly, natural compounds, including phenolic enriched foods are increasingly explored for their ameliorative effects against various metabolic diseases. Of interest is gallic acid, a trihydroxybenzoic acid that has progressively demonstrated robust anti-obesity capabilities in various experimental models. In addition to reducing excessive lipid storage in obese subjects, gallic acid has been shown to specifically target the adipose tissue to suppress lipogenesis, improve insulin signaling, and concomitantly combat raised pro-inflammatory response and oxidative stress. This review will revise mechanisms involved in the pathophysiological effects of inflammation and oxidative stress in an obese state. To better inform on its therapeutic potential and improvement of human health, available evidence reporting on the anti-obesity properties of gallic acid and its derivatives will be discussed, with emphases on its modulatory effect on molecular mechanisms involved in insulin signaling, inflammation and oxidative stress.

2 April 2007 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
AVAnnick de Vries
Annick de Vries
MHMegan C. Holmes
Megan C. Holmes
AHAreke Heijnis
Areke Heijnis
JSJürgen V. Seier
Jürgen V. Seier
JHJoritha Heerden
Joritha Heerden
JSJonathan R. Seckl
Jonathan R. Seckl
Prenatal stress or glucocorticoid administration has persisting “programming” effects on offspring in rodents and other model species. Multiple doses of glucocorticoids are in widespread use in obstetric practice. To examine the clinical relevance of glucocorticoid programming, we gave 50, 120, or 200 μg/kg/d of dexamethasone (dex50, dex120, or dex200) orally from mid-term to a singleton-bearing nonhuman primate, Chlorocebus aethiops (African vervet). Dexamethasone dose-dependently reduced maternal cortisol levels without effecting maternal blood pressure, glucose, electrolytes, or weight gain. Birth weight was unaffected by any dexamethasone dose, although postnatal growth was attenuated after dex120 and dex200. At 8 months of age, dex120 and dex200 offspring showed impaired glucose tolerance and hyperinsulinemia, with reduced (approximately 25%) pancreatic β cell number at 12 months. Dex120 and dex200 offspring had increased systolic and diastolic blood pressures at 12 months. Mild stress produced an exaggerated cortisol response in dex200 offspring, implying hypothalamic-pituitary-adrenal axis programming. The data are compatible with the extrapolation of the glucocorticoid programming hypothesis to primates and indicate that repeated glucocorticoid therapy and perhaps chronic stress in humans may have long-term effects.

1 July 1992 in Critical Care Medicine
Verified
Journal Article
Closed access
JLJapie A. Louw
Japie A. Louw
AWAnka Werbeck
Anka Werbeck
MLMaria E. J. Louw
Maria E. J. Louw
TKTheunis J. V. W. Kotze
Theunis J. V. W. Kotze
RCRosemary Cooper
Rosemary Cooper
DLDemetre Labadarios
Demetre Labadarios
To investigate the effect, if any, of the acute-phase response on blood vitamin concentrations and to test the hypothesis that these concentrations may change during stress. Open study, utilizing a volunteer sample of patients. Tertiary care center. Twenty-six healthy adult volunteers (14 female and 12 male); 25 volunteers underwent uncomplicated orthopedic surgery and one suffered traumatic limb fractures. None. The presence of a systemic acute-phase response was documented by the determination of serum C-reactive protein concentrations. Blood vitamin concentrations were determined from sequentially collected blood samples over a 7-day period, and compared with entry values. The presence of the acute-phase response was documented by significant and transient increases in C-reactive protein values. This response was accompanied by significant and transient decreases in the concentrations of leukocyte vitamin C, and in plasma concentrations of vitamin A, retinolbinding protein, vitamin E, total lipids, pyridoxal-5' -phosphate, and albumin. Blood concentrations of pyridoxal-5-phosphate, retinal-binding protein, and leukocyte vitamin C decreased to values below the respective normal ranges. These concentrations normalized without any therapeutic interventions. We demonstrated transient, but significant, decreases in blood vitamin concentrations during the acute-phase response. Recommendations regarding daily supplementation with these vitamins in clinical practice cannot be made on the basis of these results, as the functional importance of these observations is not, at present, clear. However, what is clear is that biochemical vitamin concentrations, determined during the acute-phase response, should be interpreted with care.

1 September 2008 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
MVMaryna van de Venter
Maryna van de Venter
SRSaartjie Roux
Saartjie Roux
LBLelethu C. Bungu
Lelethu C. Bungu
JLJohan Louw
Johan Louw
NCNeil R. Crouch
Neil R. Crouch
PFPeter Folb
Peter Folb

22 January 2019 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
TWTarryn Willmer
Tarryn Willmer
Rabia JohnsonRabia Johnson
Rabia Johnson
JLJohan Louw
Johan Louw
CPCarmen Pheiffer
Carmen Pheiffer
Corrigendum: Blood-Based DNA Methylation Biomarkers for Type 2 Diabetes: Potential for Clinical Applications

29 January 2018 in British Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
CACharles Awortwe
Charles Awortwe
MMMemela Makiwane
Memela Makiwane
HRHelmuth Reuter
Helmuth Reuter
CMChristo Muller
Christo Muller
JLJohan Louw
Johan Louw
BRBernd Rosenkranz
Bernd Rosenkranz